Skip to main content

Table 2 Correlation between serum exosomal miR-3913-5p expression levels in patients with NSCLC and their clinicopathological characteristics. (* p < 0.05)

From: Elevated exosome-derived miRNAs predict osimertinib resistance in non-small cell lung cancer

Clinicopathological parameters Number of patients(%) Exosomal miR-3913-5p
Low High P
Age(years), Median     0.714
 < 60 32 25 7  
 ≥ 60 31 23 8  
Gender     0.427
 Male 28 20 8  
 Female 35 28 7  
Smoking history     0.321
 Never smoking 48 38 10  
 Now/once smoking 15 10 5  
ECOG Score     0.064
 0–1 52 42 10  
 ≥ 2 11 6 5  
Primary tumor     0.64
 ≤ 4 cm 18 13 5  
 > 4 cm 45 35 10  
TNM     0.045*
 I–IVA 24 15 9  
 IVB 39 33 6  
PLT     0.024*
 Low(≤ 146) 13 13 0  
 High(> 146) 50 35 15  
LDH     0.427
 Low(≤ 199) 28 20 8  
 High(> 199) 35 28 7  
CEA     0.045*
 Low(≤ 8.605) 24 15 9  
 High(> 8.605) 39 33 6  
Distant metastasis     0.049*
 No 17 10 7  
 Yes 46 38 8  
Contralateral lung metastasis     0.434
 No 24 17 7  
 Yes 39 31 8  
Pleura metastasis     0.414
 No 32 23 9  
 Yes 31 25 6  
Bone metastasis     0.03*
 No 23 14 9  
 Yes 40 34 6  
Brain metastasis     0.112
 No 35 24 11  
 Yes 28 24 4